LCAT and Insulin resistance: Therefore, MASLD inferred from an FLI ≥ 60 confers higher plasma LCAT and, to a lesser extent, phospholipid transfer protein activity, even when accounting for T2DM, MetS, central obesity, and insulin resistance [47].